SCHEMBL26656125

SCHEMBL26656125

CC(C)(C)OC(=O)C(CC1COC1)N=C(c1ccccc1)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 1/20 0.60
KDM4E B2RXH2 1/20 0.36
PKM P14618 1/20 0.36
ADRB2 P07550 2/20 0.34
ADRB1 P08588 2/20 0.34
ADRB3 P13945 2/20 0.34
MLYCD O95822 1/20 0.34
LTB4R Q15722 1/20 0.33
LTB4R2 Q9NPC1 1/20 0.33
KLK7 P49862 3/20 0.32
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
BTN3A1 O00481 1/20 0.32
ACACB O00763 1/20 0.32
ACACA Q13085 1/20 0.32
SLC7A5 Q01650 1/20 0.32
KLK5 Q9Y337 2/20 0.32
CTSK P43235 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25319859 0.87 AAK1 (0.61) AAK1KDM4EPKMALDH1A1ACACB
SCHEMBL2652864 0.86 AAK1 (0.60) AAK1KDM4EPKMALDH1A1CTSK
SCHEMBL2652706 0.86 AAK1 (0.60) AAK1KDM4EPKMALDH1A1CTSK
SCHEMBL26804151 0.83 AAK1 (0.40) AAK1ADRB2ADRB1ADRB3ALDH1A1
SCHEMBL17643619 0.83 AAK1 (0.57) AAK1KDM4EPKMALDH1A1ACACB
SCHEMBL19376797 0.83 AAK1 (0.57) AAK1KDM4EPKMALDH1A1ACACB
SCHEMBL26656155 0.81 AAK1 (0.63) AAK1KDM4EPKMADRB2ADRB1
SCHEMBL2325860 0.79 AAK1 (0.71) AAK1ADRB2ADRB1ADRB3ALDH1A1
SCHEMBL25321838 0.79 AAK1 (0.55) AAK1
SCHEMBL18762447 0.79 AAK1 (0.67) AAK1ADRB2ADRB1ADRB3MLYCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260001889-A1 COMPOSITIONS USEFUL FOR MODULATING SPLICING SKYHAWK THERAPEUTICS INC (US) 2026-01-01 US disclosed
EP-4522622-A1 COMPOSITIONS USEFUL FOR MODULATING SPLICING Skyhawk Therapeutics, Inc. (US) 2025-03-19 EP disclosed
WO-2023220439-A1 COMPOSITIONS USEFUL FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. (US) 2023-11-16 WO disclosed
WO-2023220439-A1 COMPOSITIONS USEFUL FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. (US) 2023-11-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260001889-A1 COMPOSITIONS USEFUL FOR MODULATING SPLICING SF3B1, SF3A1, SF3B5 AAK1 3325/4885KDM4E 3466/4885PKM 4537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.